Gitnux/Report 2026

AI Therapy Industry Statistics

The global AI-powered mental health chatbot market reached $767.0 million in 2026, explore the figures behind growth, company coverage, and safety-led trends.
19Statistics
34Sources
5Sections
1Visuals
15mRead
AI Therapy Industry Statistics
How this report is researched
01Editorial Scope

An editor sets the topic, the inclusion criteria, and the evaluation framework before research starts.

02Source Research

AI search agents locate sources and extract each figure together with the document it came from.

Read our full methodology →

Search agents attach provenance to every extracted figure.

Next review: within 28 days

01 Industry overview

The AI therapy industry at a glance

The global AI-powered mental health chatbot market is estimated at $767 million in 2026, with access expanding rapidly but regulation, clinical evidence and safety remaining central industry constraints.

$767M[14]
2026 market size
33.63%[14]
2026–2034 CAGR
50%[14]
North America share, 2025
6M+[15]
Wysa users, 2025
Market size
The global AI-powered mental health chatbot market was valued at $574.0 million in 2025 and is projected to reach $767.0 million in 2026. Broader estimates for the AI-in-mental-health market put its 2025 value at $1.73 billion, reflecting differences in market definitions.[14][4]
Forecast & CAGR
The AI-powered mental health chatbot market is forecast to reach $7.8 billion by 2034, representing a 33.63% CAGR from 2026 to 2034. A broader AI-powered behavioral therapy estimate projects growth from $1.68 billion in 2025 to $3.08 billion in 2031 at a 10.73% CAGR.[14][16]
Market share & regions
North America held 50% of the global AI-powered mental health chatbot market in 2025, while the United States is expected to generate approximately $351.4 million in 2026, or about 45.8% of global sales. Asia-Pacific is identified as the fastest-growing region in broader AI-in-mental-health forecasts, with a projected 24.0% CAGR through 2035.[14][4]
Segmentation
Software accounted for the dominant share of the AI-powered mental health chatbot market in 2025, while cloud-based deployment is projected to represent 76.1% of the market in 2026. Applications span self-guided support, screening and triage, crisis escalation, care navigation and therapy support, with indications including depression, anxiety, stress, substance-use and sleep disorders.[14]
Key players & concentration
The chatbot-based mental health apps market remains fragmented: Wysa, Spring Health, Replika, Woebot Health and Limbic together held 11.8% of the market in 2025, while Wysa led with more than 2.9%. Wysa reports more than 6 million users across its dataset and reports ecosystem.[17][15]
Pricing
Wysa uses a freemium model in the United States; its App Store listing shows Wysa Premium at $99.99 per year for tools and Premium Plus at $99.99 per month for coaching and tools. Pricing varies by country and product configuration.[18]
Trends, drivers & challenges
Growth is being driven by unmet mental-health demand, clinician shortages, employer and payer procurement, and improvements in conversational AI. The principal challenges are crisis escalation, privacy, model updates, uncertain long-term clinical safety and the difficulty of distinguishing wellness tools from regulated medical devices.[14][19]
Consumer behavior & competition
Consumer products compete on always-on access, anonymity, low cost and conversational engagement, while enterprise and clinical products increasingly compete through employer contracts, payer relationships, care navigation and clinician-supervised workflows. Wysa reports more than 6 million users, illustrating the scale achieved by established consumer-oriented platforms.[15][17]
M&A
M&A activity is expanding beyond standalone chatbots: Wysa acquired virtual behavioral-health provider April Health in March 2025, adding human-care capabilities to its AI offering. Talkspace also reported acquiring AI-powered social-health and peer-support platform Wisdo Health on October 1, 2025.[20]
Regulation
The FDA is evaluating AI therapists and other generative-AI digital mental-health devices under a risk-based medical-device framework, including questions about clinical benefit, transparency, crisis handling and human oversight. As of November 2025, FDA staff stated that no AI-enabled medical device had been authorized specifically for mental-health uses, while several U.S. states were developing or implementing restrictions on AI systems representing themselves as licensed mental-health professionals.[19][21]
Latest news
In 2026, industry activity has increasingly focused on safety standards and consolidation rather than consumer chatbots alone. Wysa’s 2025 acquisition of April Health and the FDA’s continuing work on AI-enabled digital mental-health therapeutics illustrate the shift toward integrated care, clinical oversight and formal risk management.[20][19][22]

02 Ranking

Top 10 Companies in the AI Therapy Industry

The leading companies in the AI therapy industry, ranked on market impact, performance, momentum, innovation and brand popularity.

Updated November 20, 2026 · Next review December 20, 2026

Verdict

Spring Health stands out for AI-driven mental health benefit personalization because it reached a $2.5B valuation in Series E funding, while Talkiatry focuses on AI patient matching for teletherapy since it raised over $240M in venture funding.

Ranked by Overall score · How we score ↓

Editor's top 3 picks

Where to start, by need.

  1. #1 Overall · Leader in AI-driven mental health benefits

    Spring Health

    US

    Ranked #1 · 9.5 · AI-driven mental health benefits

    Why we picked it: It builds AI-driven mental health benefit experiences and personalization for employer and payer procurement use cases.

  2. Leader in AI patient matching and teletherapy

    Talkiatry

    US

    Ranked #2 · 9.3 · AI patient matching and teletherapy

    Why we picked it: It pairs AI-enabled patient matching with in-network psychiatrists for teletherapy workflows.

  3. Leader in AI intake and therapy agents

    Limbic

    GB

    Ranked #3 · 9.2 · AI intake and therapy agents

    Why we picked it: It focuses on clinical AI delivery for mental healthcare providers via intake and triage to therapy agents.

Pick 1 is the #1 company overall. Picks 2 and 3 are the highest-ranked companies in the top 5 that add a new segment.

Full ranking

Sort by
Top 10 companies in the AI therapy industry, 2026 – Gitnux ranking
#CompanyOverall ↓Company snapshot
1

Spring Health

AI-driven mental health benefits · US

9.5
2

Talkiatry

AI patient matching and teletherapy · US

9.3
3

Limbic

AI intake and therapy agents · GB

9.2
4

Slingshot AI

AI consumer wellbeing coaching · US

8.9
5

Touchkin

AI consumer wellbeing coaching · IN

8.9
6

Replika

AI companion providing emotional support and conversational therapy · US

8.6
7

Pyx Health

AI-powered loneliness and mental health support platform · US

8.6
8

Twill

AI-enhanced digital mental health therapeutics platform · US

8.5
9

Elomia Health

AI conversational mental health support · US

8.2
10

Earkick

AI mental health monitoring and support · US

7.9

How we score

  • Impact (30%): scale and weight in the market (revenue, market share, employees, market position).
  • Performance (20%): recent revenue growth and operating margin; an analyst assessment where a company does not publish them.
  • Momentum (20%): growth trajectory and future potential.
  • Innovation (15%): R&D intensity and how technologically advanced the company is.

Popularity (brand search demand, 15%) counts toward Overall but is not published as a column. Overall leaves out what is not known.

Scale Scores are shown on a 7–10 scale with one decimal; bars start at 7.0.

Cadence Recalculated when new figures are published; next review December 20, 2026.

Independence. Rankings are editorially independent. Scores, ranks, picks and the verdict follow the method above; no company can pay to change them.

Cite this ranking

APA

Samuel Norberg. (2026, November 20). Top 10 companies in the AI therapy industry. In AI Therapy Industry Statistics. Gitnux. https://gitnux.org/ai-therapy-industry-statistics/#top-companies

report visual · Projection

Global venture capital deal count for mental health AI companies

Global venture capital deal count for mental health AI companies grew from 18 in 2019 to 22 in 2024.

18 count
Start
+4.1%
CAGR · 5y
22 count
Projected
20192024
source-verifiedfiles.pitchbook.com2024

04 Statistics

Technology & AI

UK practitioners report measurable AI uptake, with 10.9% using AI for clinical research or data analysis in 2026 and 12.7% using AI-enabled notetaking or transcription apps. In the US, 29% of psychologists used AI tools at least monthly in 2025.

AI features and adoption in the AI therapy industry

  • 10.9% of UK counselling and psychotherapy practitioners used AI tools for clinical research or data analysis in 2026.[1]
  • 12.7% of UK counselling and psychotherapy practitioners used AI-enabled notetaking or transcription apps in 2026, the most-used AI-integrated tool category reported.[1]
  • 29% of U.S. psychologists used AI tools at least monthly in 2025, up from 11% in 2024, primarily for practice assistance rather than clinical therapy.[2]

05 Statistics

Market Intelligence

Market definitions vary, with the AI-in-mental-health market estimated at $1.73 billion in 2025 and the chatbot-specific market at $574.0 million in 2025. Growth remains high in forecasts, including a 21.8% revenue CAGR to 2035 from 2025.

Market size and revenue in the AI therapy industry

  • USD 1.7 billion was the 2025 global AI-in-mental-health market, covering software and services across mental-health disorders and regions.[3]
  • USD 1.73 billion was the 2025 global AI-in-mental-health market, covering software that supports therapy, screening, triage, monitoring and clinician documentation.[4]
  • USD 1.95 billion was the 2024 global AI-in-mental-health market, covering AI chatbots, virtual therapists and predictive analytics across software and services.[5]

Growth forecasts for the AI therapy industry

  • The global AI-in-mental-health market is projected to reach USD 12.44 billion by 2035 from USD 1.73 billion in 2025, at a 21.8% revenue CAGR.[4]
  • The global AI-in-mental-health market is projected to reach USD 12.69 billion by 2033, from USD 1.95 billion in 2024, at a 22.8% CAGR.[5]
  • The global AI-in-mental-health market is projected to reach USD 9.1 billion by 2033 from USD 2.1 billion in 2026, at a 23.3% CAGR during 2026–2033.[3]

06 Statistics

Customers & Revenue

Reported real-world engagement signals include Ash user night-time activity, with 66.9% having at least one overnight session in 2026. A separate Ash study classifies 52.2% as early dropouts in 2026.

Customer retention and churn in the AI therapy industry

  • 25.8% of 240,720 Headspace members using its conversational-AI tool completed at least two sessions within seven days during October 2024–July 2025.[6]
  • 25.8% of 240,720 Headspace members using its conversational-AI tool completed at least two sessions within 30 days during October 2024–July 2025.[6]
  • 66.9% of 102,684 Ash AI mental-health chatbot users had at least one overnight session between 9 p.m. and 5 a.m. in 2026.[7]
  • 52.2% of 102,684 AI mental-health chatbot users were classified as early dropouts in a 2026 real-world Ash study; the study defined this engagement phenotype from behavioral usage data.[7]

07 Statistics

Pricing & Packaging

Consumer pricing for therapy AI access is concentrated around monthly subscription levels in 2026, including $19 per month for Onward after three free sessions and $19.99 per month for Talkspace’s Tee AI after a seven-day free trial.

Price levels in the AI therapy industry

  • Onward listed AI-therapy access at $19 per month or $9 per session after three free sessions in 2026.[8]
  • Talkspace’s Tee AI mental-health guide was listed at $19.99 per month after a seven-day free trial in 2026.[9]
  • Published monthly prices for six therapy-AI scribes ranged from $19.99 to $99 in April 2026; the comparison covered Mentalyc, Upheal, Supanote, TherapyDraft, Freed and Blueprint.[10]

08 Statistics

Finance

Financing highlights continued investment into AI therapy deployments, including an $8 million pre-seed for Jimini Health launched in November 2024 and Sword Health’s $40 million June 2025 raise at a $4 billion valuation for Mind.

Funding and investment in the AI therapy industry

  • Jimini Health launched with $8 million in pre-seed funding in November 2024 for Sage, an AI-powered mental-health assistant deployed through clinician-connected care; this is a named AI therapy software financing.[11]
  • US digital mental-health companies raised $1.4 billion in venture funding in 2024, down from $4.8 billion in 2021; this parent-category figure includes AI therapy software and other digital mental-health products.[12]
  • Sword Health raised $40 million in June 2025 at a $4 billion valuation to launch Mind, an AI mental-health solution combining AI and licensed clinicians; this is a named AI therapy software financing.[13]

Key questions about the AI therapy industry

What is the 2026 market size for AI-powered mental health chatbots?
The AI-powered mental health chatbot market is estimated at $767 million in 2026.
How fast is the AI-powered mental health chatbot market growing from 2026 to 2034?
The market is forecast to reach $7.8 billion by 2034, representing a 33.63% CAGR from 2026 to 2034.
Which companies lead the AI therapy industry?
Spring Health stands out for AI-driven mental health benefit personalization because it reached a $2.5B valuation in Series E funding, while Talkiatry focuses on AI patient matching for teletherapy since it raised over $240M in venture funding.
What technology shifts are shaping AI therapy products in 2026?
Hybrid human-AI care gains ground, while safety monitoring becomes a core product layer alongside improvements in conversational AI.
How fragmented is the chatbot-based mental health apps market structure?
It remains fragmented: Wysa, Spring Health, Replika, Woebot Health and Limbic together held 11.8% of the market in 2025.
What data-driven engagement signals appear in real-world studies of AI therapy usage?
In a 2026 real-world Ash study, 52.2% of users were classified as early dropouts based on behavioral usage data, and 66.9% had at least one overnight session between 9 p.m. and 5 a.m.
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Samuel Norberg. (2026, November 20). AI Therapy Industry Statistics. Gitnux. https://gitnux.org/ai-therapy-industry-statistics
MLA
Samuel Norberg. "AI Therapy Industry Statistics." Gitnux, 20 Nov 2026, https://gitnux.org/ai-therapy-industry-statistics.
Chicago
Samuel Norberg. 2026. "AI Therapy Industry Statistics." Gitnux. https://gitnux.org/ai-therapy-industry-statistics.